Z. Ao

发表

Effects of p38 MAPK Inhibitor on Angiotensin II-Dependent Hypertension, Organ Damage, and Superoxide Anion Production

W. Bao, D. Behm, S. Nerurkar, 2007, Journal of cardiovascular pharmacology.

Identification and pharmacological characterization of native, functional human urotensin‐II receptors in rhabdomyosarcoma cell lines

N. Aiyar, Z. Ao, S. Douglas, 2004, British journal of pharmacology.

Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators

N. Aiyar, Z. Ao, D. Johns, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Urotensin II and renal function in the rat.

Z. Ao, D. Johns, S. Douglas, 2006, Kidney international.

Deletion of the UT receptor gene results in the selective loss of urotensin‐II contractile activity in aortae isolated from UT receptor knockout mice

David G. Behm, D. Behm, Z. Ao, 2003, British journal of pharmacology.

Effect of human urotensin-II infusion on hemodynamics and cardiac function.

Z. Ao, S. Douglas, R. Willette, 2003, Canadian journal of physiology and pharmacology.

IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival.

Z. Ao, S. Schlossman, M. Wu, 1998, Science.

Upregulated expression of human membrane type-5 matrix metalloproteinase in kidneys from diabetic patients.

Z. Ao, E. Ohlstein, A. M. Romanic, 2001, American journal of physiology. Renal physiology.

Regulation of the ADMA-DDAH system in endothelial cells: a novel mechanism for the sterol response element binding proteins, SREBP1c and -2.

Z. Ao, D. Johns, P. Vallance, 2010, American journal of physiology. Heart and circulatory physiology.

Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells

N. Aiyar, S. Nerurkar, Z. Ao, 2006, Molecular and Cellular Biochemistry.

Cloning and pharmacological characterization of the cat urotensin-II receptor (UT).

H. Sarau, J. Foley, N. Aiyar, 2005, Biochemical pharmacology.

NADPH oxidase-dependent and -independent mechanisms of reported inhibitors of reactive oxygen generation

Z. Ao, D. Johns, S. Douglas, 2013, Journal of enzyme inhibition and medicinal chemistry.

Inhibitory effects of putative peptidic urotensin-II receptor antagonists on urotensin-II-induced contraction of cat isolated respiratory smooth muscle.

N. Aiyar, D. Behm, Z. Ao, 2005, European journal of pharmacology.

Molecular cloning and pharmacological characterization of bovine calcitonin receptor-like receptor from bovine aortic endothelial cells.

N. Aiyar, Z. Ao, S. Douglas, 2002, Biochemical pharmacology.

A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells.

Z. Ao, S. Schlossman, Chen-Yu Zhang, 1996, Journal of immunology.

patientsmetalloproteinase in kidneys from diabetic Upregulated expression of human membrane type-5

Z. Ao, A. M. Romanic, C. L. Burns-Kurtis, 2016 .

Dendroaspis natriuretic peptide binds to the natriuretic peptide clearance receptor.

N. Aiyar, N. Elshourbagy, Z. Ao, 2007, Biochemical and biophysical research communications.

Differential modulation of endothelin ligand‐induced contraction in isolated tracheae from endothelin B (ETB) receptor knockout mice

Z. Ao, S. Douglas, P. Rigby, 2001, British journal of pharmacology.

Differential levels of “urotensin-II-like” activity determined by radio-receptor and radioimmuno-assays

David G. Behm, N. Aiyar, Z. Ao, 2004, Peptides.

erratum: Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

H. Sarau, R. Ames, J. Foley, 1999, Nature.

The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects

S. Dowell, N. Aiyar, W. Bao, 2007, British journal of pharmacology.

Quantitative analysis of orphan G protein-coupled receptor mRNAs by TaqMan Real-Time PCR: G2A and GPR4 lysophospholipid receptor expression in leukocytes and in a rat myocardial infarction-heart failure model.

P. Murdock, Z. Ao, D. Johns, 2005, Methods in molecular biology.

Murine Siva-1 and Siva-2, alternate splice forms of the mouse Siva gene, both bind to CD27 but differentially transduce apoptosis

Z. Ao, Yuan Cheng, S. Schlossman, 1999, Oncogene.

CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein.

Z. Ao, S. Jacquot, S. Schlossman, 1997, Proceedings of the National Academy of Sciences of the United States of America.

IEX-1L, an Apoptosis Inhibitor Involved in NF-κB-Mediated Cell Survival

Z. Ao, S. Schlossman, K. Prasad, 1998 .

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

H. Sarau, R. Ames, J. Foley, 1999, Nature.

Induction and detection of apoptosis in human periphery blood T-cells.

Z. Ao, J. Daley, S. Schlossman, 1997, Journal of immunological methods.

Rosiglitazone Protects against Ischemia/Reperfusion-Induced Leukocyte Adhesion in the Zucker Diabetic Fatty Rat

Z. Ao, D. Johns, S. Douglas, 2005, Journal of Pharmacology and Experimental Therapeutics.

Molecular and pharmacological characterization of genes encoding urotensin‐II peptides and their cognate G‐protein‐coupled receptors from the mouse and monkey

N. Aiyar, N. Elshourbagy, Z. Ao, 2002, British journal of pharmacology.

Role of p38 MAP kinase in postcapillary venule leukocyte adhesion induced by ischemia/reperfusion injury.

Z. Ao, D. Johns, S. Douglas, 2005, Pharmacological research.

Endothelin B receptor modulates inflammatory pain and cutaneous inflammation.

Z. Ao, S. Douglas, E. Ohlstein, 1999, Molecular pharmacology.

Heme-oxygenase induction inhibits arteriolar thrombosis in vivo: effect of the non-substrate inducer cobalt protoporphyrin.

M. Jaye, Z. Ao, D. Johns, 2009, European journal of pharmacology.

Requirement of Fas(CD95), CD45, and CD11a/CD18 in monocyte-dependent apoptosis of human T cells.

Z. Ao, M. Hegen, C. Morimoto, 1996, Journal of immunology.

Production and characterization of monoclonal antibodies against the vasoconstrictive peptide human urotensin-II.

N. Aiyar, Z. Ao, S. Douglas, 2003, Hybridoma and hybridomics.

Regulation of the ADMA-DDAH system in endothelial cells: a novel mechanism for the sterol response element binding proteins, SREBP1c and -2.

Z. Ao, D. Johns, P. Vallance, 2010, American journal of physiology. Heart and circulatory physiology.